The US government is investing over $5 billion in a new project called “Project NextGen,” aimed at accelerating the development of new COVID-19 vaccines and treatments. The initiative will collaborate with the private sector and will focus on producing long-lasting antibodies, developing vaccines that produce immunity, and creating broader vaccines that protect against several different coronaviruses. The project will cover all phases of development, from lab research to clinical trials to delivery. The goal is to provide better protection from coronaviruses, including COVID-19 and any future threats.
NATIONAL COVID-19 PREPAREDNESS PLAN MARCH 2022
The government agrees our country needs an emergency response plan considering the effects of the last crisis we faced. The White House has now released the first-ever comprehensive National Strategy for the COVID-19 Response. “This strategy focuses on building a response to this virus and other variants, giving people the tools they need to protect themselves, keeping our schools open and protect themselves, reopen our schools, and get our economy moving again.”
The National COVID-19 Preparedness Plan focuses on four key Goals
- Protect against and treat COVID-19
- Prepare for new variants
- Prevent economic and educational shutdowns
- Continue to lead the effort to vaccinate the world and save lives
“Make no mistake, President Biden will not accept just “living with COVID” any more than accept living with cancer, Alzheimer’s, or AIDS.”
“We will continue our work to stop the spread of the virus, blunt its impact on those who get infected, and deploy new treatments to dramatically reduce the occurrence of severe COVID-19 and deaths.”
In conclusion, the White House National COVID-19 Preparedness Plan is clear-eyed that new variants will arise, outlining the support of Congress’ Plan to ensure that vaccines, tests, and treatments will be updated and developed quickly to protect against these new variants.
The TechImmune Solution goes in sync with the National COVID-19 Preparedness Plan, TechImmune addresses the unmet needs as COVID-19 continues to surge globally, the staggering costs of health and economic loss, and the current spike-based vaccines losing effectiveness. We believe
in a better vaccine, inducing stronger, broader, and longer-lasting protection against new variants.